KREBS BIOCHEMICALS & INDUSTRIES
Back to All Ratios
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year EBIT Margin History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EBIT Margin(%) | -41.49 | -48.51 | -29.83 | -41.66 | -65.55 |
What is the latest EBIT Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | EBIT Margin |
|---|---|
| Mar2026 | -41.49 |
| Mar2025 | -48.51 |
| Mar2024 | -29.83 |
| Mar2023 | -41.66 |
| Mar2022 | -65.55 |
How is EBIT Margin of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | EBIT Margin | % Change | |
|---|---|---|---|
| Mar2026 | -41.49 | Negative | |
| Mar2025 | -48.51 | Negative | |
| Mar2024 | -29.83 | Negative | |
| Mar2023 | -41.66 | Negative | |
| Mar2022 | -65.55 | - | |
Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹127.5 Cr | 5.1% | 8.3% | -26.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 5.1% |
8.3% |
-26.4% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses